Researchers are working on a redesigned pump that could offer hope for those with HFpEF, which accounts for about 32 million heart failure cases globally.

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, ...

The answer is very clear that if you have MI and preserved EF, there is no benefit of using a beta-blocker. Sripal Bangalore ...

New findings reveal sotagliflozin's benefits for patients with heart failure with preserved ejection fraction without ...

A once-daily polypill containing 3 guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF) led ...

A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

Oral presentation highlights sotagliflozin's unique benefits to HFpEF patients in significantly improving cardiac and physical performance, and quality of lifeTHE WOODLANDS, Texas, Nov. 08, 2025 ...